C192H292N50O22S2 — CID 158174757
1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;tris(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-phenylazepan-2-one;5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyridazin-3-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyridin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyridin-3-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyridin-4-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyrimidin-4-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one (PubChem CID 158174757) has the molecular formula C192H292N50O22S2 and a molecular weight of 3716.91 g/mol. Its IUPAC name is 1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;tris(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-phenylazepan-2-one;5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyridazin-3-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyridin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyridin-3-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyridin-4-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyrimidin-4-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one.
| Compound Name | 1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;tris(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-phenylazepan-2-one;5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyridazin-3-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyridin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyridin-3-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyridin-4-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyrimidin-4-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one |
|---|---|
| PubChem CID | 158174757 |
| Molecular Formula | C192H292N50O22S2 |
| Molecular Weight | 3716.91 g/mol |
| Exact Mass | 3714.27 |
| IUPAC Name | 1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;tris(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-phenylazepan-2-one;5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyridazin-3-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyridin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyridin-3-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyridin-4-ylazepan-2-one;5-methyl-3-(methylamino)-1-pyrimidin-4-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one |
| SMILES | CCc1nc(N2CCC(C)CC(NC)C2=O)no1.CNC1CC(C)CCN(c2ccc[nH]2)C1=O.CNC1CC(C)CCN(c2ccccc2)C1=O.CNC1CC(C)CCN(c2ccccn2)C1=O.CNC1CC(C)CCN(c2cccnc2)C1=O.CNC1CC(C)CCN(c2cccnn2)C1=O.CNC1CC(C)CCN(c2ccco2)C1=O.CNC1CC(C)CCN(c2cccs2)C1=O.CNC1CC(C)CCN(c2ccncc2)C1=O.CNC1CC(C)CCN(c2ccncn2)C1=O.CNC1CC(C)CCN(c2cnccn2)C1=O.CNC1CC(C)CCN(c2ncco2)C1=O.CNC1CC(C)CCN(c2ncco2)C1=O.CNC1CC(C)CCN(c2ncco2)C1=O.CNC1CC(C)CCN(c2nccs2)C1=O.CNC1CC(C)CCN(c2noc(C)n2)C1=O |
| InChI | InChI=1S/C14H20N2O.3C13H19N3O.C12H20N4O2.3C12H18N4O.C12H19N3O.C12H18N2O2.C12H18N2OS.C11H18N4O2.3C11H17N3O2.C11H17N3OS/c1-11-8-9-16(12-6-4-3-5-7-12)14(17)13(10-11)15-2;1-10-5-8-16(11-3-6-15-7-4-11)13(17)12(9-10)14-2;1-10-5-7-16(11-4-3-6-15-9-11)13(17)12(8-10)14-2;1-10-6-8-16(12-5-3-4-7-15-12)13(17)11(9-10)14-2;1-4-10-14-12(15-18-10)16-6-5-8(2)7-9(13-3)11(16)17;1-9-3-6-16(11-8-14-4-5-15-11)12(17)10(7-9)13-2;1-9-4-6-16(11-3-5-14-8-15-11)12(17)10(7-9)13-2;1-9-5-7-16(11-4-3-6-14-15-11)12(17)10(8-9)13-2;1-9-5-7-15(11-4-3-6-14-11)12(16)10(8-9)13-2;2*1-9-5-6-14(11-4-3-7-16-11)12(15)10(8-9)13-2;1-7-4-5-15(10(16)9(6-7)12-3)11-13-8(2)17-14-11;4*1-8-3-5-14(11-13-4-6-16-11)10(15)9(7-8)12-2/h3-7,11,13,15H,8-10H2,1-2H3;3-4,6-7,10,12,14H,5,8-9H2,1-2H3;3-4,6,9-10,12,14H,5,7-8H2,1-2H3;3-5,7,10-11,14H,6,8-9H2,1-2H3;8-9,13H,4-7H2,1-3H3;4-5,8-10,13H,3,6-7H2,1-2H3;3,5,8-10,13H,4,6-7H2,1-2H3;3-4,6,9-10,13H,5,7-8H2,1-2H3;3-4,6,9-10,13-14H,5,7-8H2,1-2H3;2*3-4,7,9-10,13H,5-6,8H2,1-2H3;7,9,12H,4-6H2,1-3H3;4*4,6,8-9,12H,3,5,7H2,1-2H3 |
| InChIKey | FXWIFVQBIQQQOL-UHFFFAOYSA-N |
| XLogP | 20.19 |
| TPSA | 831.20 Ų |
| H-Bond Donors | 17 |
| H-Bond Acceptors | 57 |
| Rotatable Bonds | 33 |
| Heavy Atoms | 266 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3716.91 |
| LogP ≤ 5 | 20.19 |
| H-Bond Donors ≤ 5 | 17 |
| H-Bond Acceptors ≤ 10 | 57 |